Award to Dr. Walter Swardfager, from Sunnybrook Research Institute, will support a proof-of-mechanism clinical trial ...
Learn the common signs of Alzheimer’s disease, how it progresses, and steps families can take for diagnosis and care.
EARLIER TREATMENT with donanemab could increase the lifetime benefits of Alzheimer’s care, according to a US modelling study ...
Columbia researchers found that excess fibronectin make brain blood vessels leak decades before symptoms of cognitive decline ...
1don MSN
Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.
Not all researchers are convinced that the brain changes detected via MRI are robust enough to become a diagnostic tool. But ...
13hon MSN
Is this the cure for Alzheimer’s?
We’re about to find out if an experimental surgery can treat Alzheimer’s disease.
A major focus of R&D in the Alzheimer’s disease therapeutic space is preventing the accumulation of amyloid beta.
The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.
University of Wyoming researchers discovered that mice that exercised lowered their risk for contracting Alzheimer’s disease, ...
Explore how blood-based biomarkers perform across Alzheimer’s disease stages, including AIBL Study findings comparing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results